Skip to content
HowShorted

ANAVEX LIFE SCIENCES CORP. short interest in 2022

In 2022, ANAVEX LIFE SCIENCES CORP.'s disclosed short interest ran from 6.40% of shares outstanding on 14 Jan 2022 to 23.41% on 30 Dec 2022, a change of +17.01 percentage points. The year's high was 23.41% on 30 Dec 2022 and its low 6.40% on 14 Jan 2022, averaging 12.11% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.25 days on 15 Sep 2022. Full history: ANAVEX LIFE SCIENCES CORP..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ANAVEX LIFE SCIENCES CORP. in 2022

2022 in figures

Start of year
6.40% (14 Jan 2022)
End of year
23.41% (30 Dec 2022)
Change
+17.01 pp
High
23.41% (30 Dec 2022)
Low
6.40% (14 Jan 2022)
Average
12.11%
Highest days to cover
14.25 (15 Sep 2022)
SEC filings marked
4

Every report in 2022

ANAVEX LIFE SCIENCES CORP. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20226.40%4.82
31 Jan 20227.73%5.04
15 Feb 202210.31%3.7910-Q filed
28 Feb 202210.30%7.61
15 Mar 202210.56%8.26
31 Mar 202210.00%7.14
14 Apr 202210.35%11.20
29 Apr 202210.68%10.66
13 May 202211.34%8.3610-Q filed
31 May 202211.51%11.03
15 Jun 202212.27%11.56
30 Jun 202211.25%7.32
15 Jul 202210.67%8.99
29 Jul 202211.27%10.19
15 Aug 202210.81%10.7410-Q filed
31 Aug 202211.68%12.89
15 Sep 202212.49%14.25
30 Sep 202213.16%10.96
14 Oct 202212.89%13.97
31 Oct 202212.97%10.25
15 Nov 202213.04%10.31
30 Nov 202215.28%6.6610-K filed
15 Dec 202220.24%2.23
30 Dec 202223.41%12.83

See also: ANAVEX LIFE SCIENCES CORP.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.